News Center

Find the latest information and updates from Hebebio here

Hebe Biotechnology Appoints Industry Insider Dr. Hannes Hentze as Chief Development Officer to Advance Next-Generation GLP-1 RA Weight Loss Therapy
2025-04-09 16:30

Interested in opportunities with Hebebio?